StocksMedium•5 November 2026•
1 min read
Santen Pharmaceutical Reports Q2 EPS of ¥48.00 and Revenue of ¥143.3 Billion
Key Facts
1Santen Pharmaceutical reported Q2 GAAP EPS of ¥48.00.
2The company's revenue reached ¥143.3B for the second quarter.
Santen Pharmaceutical reported Q2 GAAP earnings per share of ¥48.00. Seeking Alpha reported that the company's total revenue reached ¥143.3 billion for the second quarter.
The financial results were released as part of Santen Pharmaceutical's scheduled quarterly performance reporting. The figures reflect the company's operational activities within the pharmaceutical sector during the second quarter of 2026.